Matches in SemOpenAlex for { <https://semopenalex.org/work/W2076277145> ?p ?o ?g. }
Showing items 1 to 99 of
99
with 100 items per page.
- W2076277145 endingPage "1440" @default.
- W2076277145 startingPage "1432" @default.
- W2076277145 abstract "To establish the clinical equivalence (noninferiority) of one tablet containing abacavir 300 mg-lamivudine 150 mg-zidovudine 300 mg (Trizivir) versus a tablet containing lamivudine 150 mg-zidovudine 300 mg (Combivir) given with one abacavir (ABC) 300-mg tablet, administered twice/day, in antiretroviral-experienced, human immunodeficiency virus (HIV)-1-infected patients.Randomized, open-label, parallel-group, multicenter, formulation-switch study.Twenty seven outpatient treatment sites.Adults with HIV-1 RNA levels of 400 copies/ml or less and CD4+ cell counts above 200 cells/mm3 who had been treated for 16 weeks or more with highly active antiretroviral therapy containing Combivir-ABC.Patients were randomized 1:1 to Trizivir (97 patients) or Combivir-ABC (98) for 24 weeks.The primary study end point was the proportion of patients who maintained less than a 0.5-log10 increase from baseline in HIV-1 RNA (virologic success) through week 24. Clinical equivalence of the treatments was established if the 95.1% lower confidence limit (LCL) for the difference in proportion of virologic success with Trizivir minus Combivir-ABC was -0.12 or greater. Trizivir was clinically equivalent to Combivir-ABC. The intent-to-treat observed analysis at week 24 with Trizivir and Combivir-ABC showed a similar rate of virologic success (83% [80/97] and 77% [75/98], respectively, 95.1% LCL -0.026), of patients with HIV-1 RNA levels of 400 or fewer copies/ml (99% [82/83] and 93% [77/83], respectively, 95.1% LCL 0.021), and of patients with HIV-1 RNA levels of fewer than 50 copies/ml (89% [74/83] and 77% [64/83], respectively, 95.1% LCL 0.038). The intent-to-treat missing = failure analysis showed comparable results. Changes in CD4+ cell count from baseline, overall mean self-reported adherence (Trizivir 97%, Combivir-ABC 92%), and adverse events did not differ significantly between treatments. No ABC-related hypersensitivity reactions occurred.Trizivir was clinically equivalent to Combivir-ABC and may be substituted for the latter to simplify treatment and reduce pill burden." @default.
- W2076277145 created "2016-06-24" @default.
- W2076277145 creator A5012080878 @default.
- W2076277145 creator A5015721603 @default.
- W2076277145 creator A5052106640 @default.
- W2076277145 creator A5059577442 @default.
- W2076277145 creator A5061912045 @default.
- W2076277145 creator A5079664351 @default.
- W2076277145 creator A5079973774 @default.
- W2076277145 creator A5084232309 @default.
- W2076277145 creator A5084991191 @default.
- W2076277145 date "2003-11-01" @default.
- W2076277145 modified "2023-09-27" @default.
- W2076277145 title "Twice-Daily Trizivir versus Combivir-Abacavir in Antiretroviral-Experienced Adults with Human Immunodeficiency Virus-1 Infection: A Formulation-Switch Trial" @default.
- W2076277145 cites W1982612158 @default.
- W2076277145 cites W1987972580 @default.
- W2076277145 cites W1989307318 @default.
- W2076277145 cites W1998188886 @default.
- W2076277145 cites W2043589573 @default.
- W2076277145 cites W2045206297 @default.
- W2076277145 cites W2048436716 @default.
- W2076277145 cites W2051347255 @default.
- W2076277145 cites W2060390219 @default.
- W2076277145 cites W2081568659 @default.
- W2076277145 cites W2094465161 @default.
- W2076277145 cites W2102507669 @default.
- W2076277145 cites W2116204495 @default.
- W2076277145 cites W2126311717 @default.
- W2076277145 cites W2129710521 @default.
- W2076277145 cites W2133315239 @default.
- W2076277145 cites W2166670196 @default.
- W2076277145 cites W2170804912 @default.
- W2076277145 doi "https://doi.org/10.1592/phco.23.14.1432.31944" @default.
- W2076277145 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/14620390" @default.
- W2076277145 hasPublicationYear "2003" @default.
- W2076277145 type Work @default.
- W2076277145 sameAs 2076277145 @default.
- W2076277145 citedByCount "1" @default.
- W2076277145 countsByYear W20762771452014 @default.
- W2076277145 crossrefType "journal-article" @default.
- W2076277145 hasAuthorship W2076277145A5012080878 @default.
- W2076277145 hasAuthorship W2076277145A5015721603 @default.
- W2076277145 hasAuthorship W2076277145A5052106640 @default.
- W2076277145 hasAuthorship W2076277145A5059577442 @default.
- W2076277145 hasAuthorship W2076277145A5061912045 @default.
- W2076277145 hasAuthorship W2076277145A5079664351 @default.
- W2076277145 hasAuthorship W2076277145A5079973774 @default.
- W2076277145 hasAuthorship W2076277145A5084232309 @default.
- W2076277145 hasAuthorship W2076277145A5084991191 @default.
- W2076277145 hasConcept C126322002 @default.
- W2076277145 hasConcept C159047783 @default.
- W2076277145 hasConcept C168563851 @default.
- W2076277145 hasConcept C2522874641 @default.
- W2076277145 hasConcept C2776452011 @default.
- W2076277145 hasConcept C2777869810 @default.
- W2076277145 hasConcept C2779465607 @default.
- W2076277145 hasConcept C2780216070 @default.
- W2076277145 hasConcept C2780593183 @default.
- W2076277145 hasConcept C2780727368 @default.
- W2076277145 hasConcept C3013748606 @default.
- W2076277145 hasConcept C44249647 @default.
- W2076277145 hasConcept C71924100 @default.
- W2076277145 hasConcept C90924648 @default.
- W2076277145 hasConceptScore W2076277145C126322002 @default.
- W2076277145 hasConceptScore W2076277145C159047783 @default.
- W2076277145 hasConceptScore W2076277145C168563851 @default.
- W2076277145 hasConceptScore W2076277145C2522874641 @default.
- W2076277145 hasConceptScore W2076277145C2776452011 @default.
- W2076277145 hasConceptScore W2076277145C2777869810 @default.
- W2076277145 hasConceptScore W2076277145C2779465607 @default.
- W2076277145 hasConceptScore W2076277145C2780216070 @default.
- W2076277145 hasConceptScore W2076277145C2780593183 @default.
- W2076277145 hasConceptScore W2076277145C2780727368 @default.
- W2076277145 hasConceptScore W2076277145C3013748606 @default.
- W2076277145 hasConceptScore W2076277145C44249647 @default.
- W2076277145 hasConceptScore W2076277145C71924100 @default.
- W2076277145 hasConceptScore W2076277145C90924648 @default.
- W2076277145 hasIssue "11" @default.
- W2076277145 hasLocation W20762771451 @default.
- W2076277145 hasLocation W20762771452 @default.
- W2076277145 hasOpenAccess W2076277145 @default.
- W2076277145 hasPrimaryLocation W20762771451 @default.
- W2076277145 hasRelatedWork W1965635372 @default.
- W2076277145 hasRelatedWork W1993086185 @default.
- W2076277145 hasRelatedWork W1996421607 @default.
- W2076277145 hasRelatedWork W2032073239 @default.
- W2076277145 hasRelatedWork W2052332986 @default.
- W2076277145 hasRelatedWork W2093984759 @default.
- W2076277145 hasRelatedWork W2100307468 @default.
- W2076277145 hasRelatedWork W2135124387 @default.
- W2076277145 hasRelatedWork W2164766844 @default.
- W2076277145 hasRelatedWork W2321905088 @default.
- W2076277145 hasVolume "23" @default.
- W2076277145 isParatext "false" @default.
- W2076277145 isRetracted "false" @default.
- W2076277145 magId "2076277145" @default.
- W2076277145 workType "article" @default.